Skip to main content
NGL Fine Chem Ltd. logo

NGL Fine Chem Ltd. — Investor Relations & Filings

Ticker · NGLFINE ISIN · INE887E01022 LEI · 335800X5TUU2OAV19X07 BSE.NS Manufacturing
Open in API
Filings indexed 309 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country IN India
Listing BSE.NS NGLFINE

About NGL Fine Chem Ltd.

https://www.nglfinechem.com

NGL Fine Chem Ltd. specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human healthcare sectors. The company focuses on high-quality chemical synthesis, producing a diverse range of products including anthelmintics, ectoparasiticides, and specialty chemicals. Key products in its portfolio include Nitroxynil, Closantel, Oxyclozanide, and Triclabendazole. Operating with Good Manufacturing Practice (GMP) standards, the firm serves a global clientele, providing customized manufacturing solutions and maintaining a strong emphasis on research and development to enhance process efficiency and product quality. Its technical expertise lies in complex chemical reactions and large-scale production of niche pharmaceutical components.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a compliance disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, confirming that the promoters have not created any encumbrance on their shareholdings for the year ended March 31, 2026. It does not present financial statements or act as a full financial report; instead it is a regulatory compliance filing under takeover regulations. There is no change in share thresholds or any corporate action like a buyback. Thus it falls under general regulatory announcements (Regulatory Filings).
2026-06-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 96% confidence The document is titled “Transcript of the Earnings Call – Q4 & FY 26,” contains the full text of an earnings conference call including Q&A, moderator instructions, management remarks and participant questions. This matches the definition of a Call Transcript (CT). It is not merely an earnings highlights release (ER) nor an annual or quarterly report. Therefore, the correct classification is CT.
2026-05-30 English
Transcript of the Earnings Call - Q4 & FY 26
Call Transcript Classification · 99% confidence The document is explicitly titled “Transcript of the Earnings Call – Q4 & FY 26” and contains the full text of a conference call with opening remarks, financial performance discussion, and a Q&A session. It is not merely an announcement but the actual transcript of an earnings conference call. This matches the definition of a Call Transcript (CT).
2026-05-30 English
Annual Secretarial Compliance Report for FY 2025-26
Regulatory Filings Classification · 92% confidence The document is a Secretarial Compliance Report prepared by the Practicing Company Secretary under SEBI LODR regulations. It is primarily an officer’s attestation/certification of statutory and regulatory compliance rather than a full financial report, management discussion, or specific notice (e.g., earnings release, AGM materials). Under the certification rule, such attestations are classified as general regulatory filings. Therefore, it falls into the Regulatory Filings (RNS) category.
2026-05-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 80% confidence The document is a short SEBI Regulation 30 disclosure letter to BSE and NSE informing investors that the audio recording of the Q4 & FY26 earnings conference call has been uploaded to the company website. It does not contain financial results, actual financial data, or presentation slides, nor is it the call transcript itself. This is a routine regulatory/compliance announcement under Listing Obligations, best classified as a general Regulatory Filing (RNS).
2026-05-25 English
Audio Recording of Earning Conference Call Q4 & FY26
Report Publication Announcement Classification · 92% confidence The document is a brief compliance letter to stock exchanges under SEBI LODR Regulation 30, informing that the audio recording of the Q4 & FY26 earnings conference call has been uploaded and providing a download link. It does not contain financial data or the earnings release itself but merely announces publication of a related material. Under the “menu vs meal” rule, this is an announcement of publication, fitting the Report Publication Announcement category.
2026-05-25 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.